Development of novel prediction models for nodal and distant metastasis in G1 and G2 colorectal neuroendocrine tumors

[1]  H. Kashida,et al.  Characteristics of colorectal neuroendocrine tumors in patients prospectively enrolled in a Japanese multicenter study: a first report from the C-NET STUDY , 2022, Journal of Gastroenterology.

[2]  Qiyun Tang,et al.  Prognostic Evaluation of Patients with Rectal Neuroendocrine Neoplasms and Hepatic Metastases: A SEER Database Analysis , 2022, Journal of oncology.

[3]  J. Cai,et al.  Nomogram for the prediction of lymph node metastasis and survival outcomes in rectal neuroendocrine tumour patients undergoing resection. , 2021, Journal of gastrointestinal oncology.

[4]  H. Chang,et al.  Risk Factors for Lymph Node Metastasis and Oncologic Outcomes in Small Rectal Neuroendocrine Tumors with Lymphovascular Invasion , 2021, Gut and liver.

[5]  Bing Zhang,et al.  Comparison of 68Ga-DOTANOC and 18F-FDG PET-CT Scans in the Evaluation of Primary Tumors and Lymph Node Metastasis in Patients With Rectal Neuroendocrine Tumors , 2021, Frontiers in Endocrinology.

[6]  Jia Hu,et al.  Risk and prognostic nomograms for colorectal neuroendocrine neoplasm with liver metastasis: a population-based study , 2021, International Journal of Colorectal Disease.

[7]  Yiwei Li,et al.  Grade G2 Rectal Neuroendocrine Tumor Is Much More Invasive Compared With G1 Tumor , 2021, Frontiers in Oncology.

[8]  H. Ueno,et al.  A nationwide, multi‐institutional collaborative retrospective study of colorectal neuroendocrine tumors in Japan , 2020, Annals of gastroenterological surgery.

[9]  Wei Wu,et al.  Endoscopic and surgical treatment of T1N0M0 colorectal neuroendocrine tumors: a population-based comparative study , 2020, Surgical Endoscopy.

[10]  Minhu Chen,et al.  Development of a novel scoring system based on endoscopic appearance for management of rectal neuroendocrine tumors , 2020, Endoscopy.

[11]  C. Hajdu,et al.  Characterization of a Novel Entity of G3 (High-grade Well-differentiated) Colorectal Neuroendocrine Tumors (NET) in the SEER Database , 2020, American journal of clinical oncology.

[12]  I. Endo,et al.  A novel risk‐scoring system for predicting lymph node metastasis of rectal neuroendocrine tumors , 2020, Annals of gastroenterological surgery.

[13]  J. Hrabe.  Neuroendocrine Tumors of the Appendix, Colon, and Rectum. , 2020, Surgical oncology clinics of North America.

[14]  J. G. van den Berg,et al.  Change in incidence, characteristics and management of colorectal neuroendocrine tumours in the Netherlands in the last decade , 2019, United European gastroenterology journal.

[15]  Ping Chen,et al.  The effect of marital status on the survival of patients with colorectal neuroendocrine neoplasms: an analysis of the SEER database. , 2019, Revista Espanola de Enfermedades Digestivas.

[16]  D. Metz,et al.  Grade is a Dominant Risk Factor for Metastasis in Patients with Rectal Neuroendocrine Tumors , 2019, Annals of Surgical Oncology.

[17]  S. Maithel,et al.  A novel preoperative risk score to predict lymph node positivity for rectal neuroendocrine tumors: An NCDB analysis to guide operative technique , 2019, Journal of surgical oncology.

[18]  S. Nagayama,et al.  Difficulty of predicting lymph node metastasis on CT in patients with rectal neuroendocrine tumors , 2019, PloS one.

[19]  S. Kim,et al.  Is endoscopic ultrasonography essential for endoscopic resection of small rectal neuroendocrine tumors? , 2017, World journal of gastroenterology.

[20]  J. Oh,et al.  Lymph node size is not a reliable criterion for predicting nodal metastasis in rectal neuroendocrine tumours , 2016, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[21]  D. Metz,et al.  Consensus guidelines for the management and treatment of neuroendocrine tumors. , 2013, Pancreas.

[22]  M. Papotti,et al.  ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms: Colorectal Neuroendocrine Neoplasms , 2011, Neuroendocrinology.

[23]  A. Benson,et al.  The NANETS Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Neuroendocrine Tumors (NETs): Well-Differentiated NETs of the Distal Colon and Rectum , 2010, Pancreas.

[24]  Michael A Choti,et al.  NCCN Clinical Practice Guidelines in Oncology: neuroendocrine tumors. , 2009, Journal of the National Comprehensive Cancer Network : JNCCN.